China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: N/A
- Symbol: NYSE:CO
- CUSIP: N/A
- Web: www.chinacordbloodcorp.com
Capitalization:- Market Cap: $871.66 million
- Outstanding Shares: 113,524,000
Average Prices:- 50 Day Moving Avg: $12.57
- 200 Day Moving Avg: $9.17
- 52 Week Range: $4.27 - $14.95
P/E:- Trailing P/E Ratio: 38.83
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $122.77 million
- Price / Sales: 11.10
- Book Value: $3.88 per share
- Price / Book: 3.09
Profitability:- EBIDTA: $52.4 million
- Net Margins: 22.07%
- Return on Equity: 8.64%
- Return on Assets: 3.50%
Debt:- Current Ratio: 8.27%
- Quick Ratio: 8.19%
Misc:- Average Volume: 502,180 shs.
- Beta: 0.91
- Short Ratio: 1.24
Frequently Asked Questions for China Cord Blood Corporation (NYSE:CO)
What is China Cord Blood Corporation's stock symbol?
China Cord Blood Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."
How were China Cord Blood Corporation's earnings last quarter?
China Cord Blood Corporation (NYSE:CO) posted its earnings results on Wednesday, August, 23rd. The company reported $0.09 earnings per share for the quarter. The company had revenue of $33.07 million for the quarter. China Cord Blood Corporation had a return on equity of 8.64% and a net margin of 22.07%. View China Cord Blood Corporation's Earnings History.
When will China Cord Blood Corporation make its next earnings announcement?
Who are some of China Cord Blood Corporation's key competitors?
Some companies that are related to China Cord Blood Corporation include Tenet Healthcare Corporation (THC), HMS Holdings Corp (HMSY), Community Health Systems (CYH), HealthStream (HSTM), Kindred Healthcare (KND), American Renal Associates Holdings (ARA), Georgia Healthcare Group PLC (GHG), Cambian Group PLC (CMBN), Concord Medical Services Holdings Limited (CCM), Nobilis Health Corp (HLTH), Cancer Genetics (CGIX), The Joint Corp. (JYNT), Streamline Health Solutions (STRM), Air Methods Corp (AIRM), Surgical Care Affiliates (SCAI) and TeamHealth Holdings (TMH).
Who are China Cord Blood Corporation's key executives?
China Cord Blood Corporation's management team includes the folowing people:
- Yuen Kam, Chairman of the Board
- Ting Zheng, Chief Executive Officer, Director, Chief Executive Officer - Beijing
- Albert Chen, Chief Financial Officer, Director
- Rui Arashiyama, Chief Executive Officer - Guangdong and Zhejiang Divisions
- Xin Xu, Chief Technology Officer
- Mark D. Chen, Independent Non-Executive Director
- Ken Lu, Independent Non-Executive Director
- Jennifer J. Weng, Independent Non-Executive Director
Who owns China Cord Blood Corporation stock?
China Cord Blood Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include GLG Partners LP (1.25%), Acadian Asset Management LLC (0.85%), Lazard Asset Management LLC (0.20%), California Public Employees Retirement System (0.11%), Spark Investment Management LLC (0.16%) and SG Americas Securities LLC (0.08%). View Institutional Ownership Trends for China Cord Blood Corporation.
Who sold China Cord Blood Corporation stock? Who is selling China Cord Blood Corporation stock?
Who bought China Cord Blood Corporation stock? Who is buying China Cord Blood Corporation stock?
China Cord Blood Corporation's stock was bought by a variety of institutional investors in the last quarter, including Lazard Asset Management LLC, SG Americas Securities LLC, Spark Investment Management LLC, Arrowstreet Capital Limited Partnership, Acadian Asset Management LLC, Citadel Advisors LLC, Virtu KCG Holdings LLC and Parametrica Management Ltd. View Insider Buying and Selling for China Cord Blood Corporation.
How do I buy China Cord Blood Corporation stock?
Shares of China Cord Blood Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is China Cord Blood Corporation's stock price today?
One share of China Cord Blood Corporation stock can currently be purchased for approximately $12.00.
MarketBeat Community Rating for China Cord Blood Corporation (NYSE CO)MarketBeat's community ratings are surveys of what our community members think about China Cord Blood Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for China Cord Blood Corporation (NYSE:CO)Earnings History by Quarter for China Cord Blood Corporation (NYSE CO)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/15/2017 | | | | | | | N/A |  |
| 8/23/2017 | 6/30/2017 | | $0.09 | | $33.07 million | View | N/A | |
| 6/21/2017 | 3/31/2017 | $0.05 | $0.07 | | $29.35 million | View | N/A | |
| 2/24/2017 | Q317 | $0.04 | $0.10 | | $28.93 million | View | Listen | |
| 11/17/2016 | Q217 | $0.04 | $0.03 | $27.37 million | $27.61 million | View | Listen | |
| 8/22/2016 | Q117 | $0.03 | $0.03 | $26.23 million | $26.00 million | View | N/A | |
| 6/14/2016 | Q416 | $0.03 | $0.03 | $25.87 million | $24.31 million | View | Listen | |
| 11/23/2015 | Q216 | $0.04 | $0.05 | $26.42 million | $27.00 million | View | Listen | |
| 8/19/2015 | Q116 | $0.04 | $0.03 | $25.81 million | $26.70 million | View | Listen | |
| 6/18/2015 | Q415 | $0.05 | $0.04 | $25.88 million | $26.30 million | View | Listen | |
| 2/25/2015 | Q315 | $0.06 | $0.07 | $26.35 million | $26.90 million | View | Listen | |
| 11/25/2014 | Q2 | $0.06 | $0.06 | $25.30 million | $24.78 million | View | Listen | |
| 8/28/2014 | Q1 | $0.06 | $0.06 | $24.78 million | $24.72 million | View | Listen | |
| 6/18/2014 | Q414 | $0.07 | $0.07 | $24.41 million | $24.44 million | View | N/A | |
| 2/24/2014 | Q3 | $0.06 | $0.07 | $24.22 million | $24.90 million | View | Listen | |
| 1/31/2014 | Q4 | | ($0.25) | | | View | N/A | |
| 11/15/2013 | Q2 | $0.06 | $0.06 | $22.32 million | $23.10 million | View | Listen | |
| 8/26/2013 | Q1 2014 | $0.04 | $0.07 | $21.62 million | $21.00 million | View | Listen | |
| 6/18/2013 | Q4 2013 | $0.02 | $0.05 | $16.59 million | $21.40 million | View | Listen | |
| 11/19/2012 | Q312 | | $0.05 | $18.53 million | $20.40 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for China Cord Blood Corporation (NYSE:CO)2017 EPS Consensus Estimate: $0.16
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2017 | 1 | $0.04 | $0.04 | $0.04 |
| Q3 2017 | 1 | $0.04 | $0.04 | $0.04 |
| Q4 2017 | 1 | $0.05 | $0.05 | $0.05 |
(Data provided by Zacks Investment Research)
Dividend History for China Cord Blood Corporation (NYSE:CO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for China Cord Blood Corporation (NYSE:CO)Institutional Ownership Percentage: 13.33%
Insider Trades by Quarter for China Cord Blood Corporation (NYSE:CO)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 1/21/2015 | Kent C Mccarthy | Insider | Buy | 20,000 | $4.60 | $92,000.00 | |
| 1/16/2015 | Kent C Mccarthy | Insider | Buy | 50,000 | $4.30 | $215,000.00 | |
| 1/14/2015 | Private Equity Fund Jayhawk II | Insider | Buy | 10,000 | $4.52 | $45,200.00 | |
| 1/12/2015 | Private Equity Fund Jayhawk II | Insider | Buy | 50,000 | $4.69 | $234,500.00 | |
| 11/28/2014 | Robert Douglas Cudney | Insider | Buy | 200,000 | $0.01 | $1,000.00 | |
| 11/17/2014 | Kent C Mccarthy | Insider | Buy | 26,754 | $4.70 | $125,743.80 | |
| 11/6/2014 | Kent C Mccarthy | Insider | Buy | 150,000 | $5.16 | $774,000.00 | |
| 9/29/2014 | Kent C Mccarthy | Insider | Buy | 10,000 | $5.00 | $50,000.00 | |
| 9/10/2014 | Kent C Mccarthy | Insider | Buy | 9,900 | $4.98 | $49,302.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for China Cord Blood Corporation (NYSE:CO)
Latest Headlines for China Cord Blood Corporation (NYSE:CO)
| Source: |
|
| Date | Headline |
|---|
 | HealthSouth Corporation (HLS) & China Cord Blood Corporation (CO) Critical Survey
www.americanbankingnews.com - September 18 at 6:23 PM |
| Acadia Healthcare (ACHC) versus China Cord Blood Corporation (CO) Head-To-Head Review
www.americanbankingnews.com - September 16 at 2:46 AM |
 | Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021
www.bizjournals.com - September 13 at 6:41 PM |
 | Earnings Review and Free Research Report: Charles River’s Q2 Results Outshined Market Expectations
finance.yahoo.com - September 1 at 5:43 PM |
| Earnings Review and Free Research Report: Charles River’s Q2 Results Outshined Market Expectations
finance.yahoo.com - September 1 at 5:43 PM |
| Universal Health Services (UHS) versus China Cord Blood Corporation (CO) Critical Analysis
www.americanbankingnews.com - September 1 at 2:44 AM |
| See what the IHS Markit Score report has to say about China Cord Blood Corp.
finance.yahoo.com - August 30 at 6:25 PM |
 | China Cord Blood Reports Adoption Of 10b5-1 Sales Plan - Quick Facts
www.nasdaq.com - August 28 at 5:17 PM |
| China Cord Blood Corporation Announces Adoption of 10b5-1 Sales Plan
finance.yahoo.com - August 28 at 5:17 PM |
| China Cord Blood Corp.: Leads amongst peers with strong fundamentals
finance.yahoo.com - August 25 at 8:22 PM |
| ETFs with exposure to China Cord Blood Corp. : August 25, 2017
finance.yahoo.com - August 25 at 8:22 PM |
 | China Cord Blood's (CO) Management on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - August 24 at 11:17 PM |
| Edited Transcript of CO earnings conference call or presentation 24-Aug-17 12:00pm GMT
finance.yahoo.com - August 24 at 11:17 PM |
| Investor Network: China Cord Blood Corporation to Host Earnings Call
finance.yahoo.com - August 24 at 5:32 PM |
| China Cord Blood Corporation (CO) Releases Quarterly Earnings Results
www.americanbankingnews.com - August 24 at 10:26 AM |
 | China Cord Blood Corp Q1 Income Climbs 340%
www.rttnews.com - August 23 at 5:59 PM |
| China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2018
finance.yahoo.com - August 23 at 5:59 PM |
| China Cord Blood posts 1Q profit
finance.yahoo.com - August 23 at 5:59 PM |
| China Cord Blood Corporation to Report First Quarter Fiscal 2018 Financial Results
finance.yahoo.com - August 17 at 6:39 PM |
| ETFs with exposure to China Cord Blood Corp. : August 14, 2017
finance.yahoo.com - August 14 at 5:46 PM |
| China Cord Blood Corporation (NYSE:CO) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - August 14 at 1:46 AM |
| China Cord Blood Corporation (CO) Sees Significant Drop in Short Interest
www.americanbankingnews.com - August 2 at 7:10 AM |
| China Cord Blood Corp. :CO-US: Earnings Analysis: Q4, 2017 By the Numbers : July 31, 2017
finance.yahoo.com - July 31 at 5:19 PM |
| July 26, 2017 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
finance.yahoo.com - July 26 at 5:58 PM |
| China Cord Blood Corporation Files Its Annual Report on Form 20-F
finance.yahoo.com - July 25 at 5:20 PM |
| China Cord Blood Corp (NYSE:CO) Sees Significant Growth in Short Interest
www.americanbankingnews.com - July 20 at 7:26 AM |
| Stock Performance Review on Medical Labs & Research Industry -- PAREXEL, China Cord Blood, ICON, and PRA Health Sciences
www.bizjournals.com - July 19 at 6:34 PM |
| Here's What a Breakup of Procter & Gamble Would Look Like
finance.yahoo.com - July 18 at 6:54 PM |
| China Cord Blood Corporation (CO) and Chemed Corp. (CHE) Head to Head Survey
www.americanbankingnews.com - June 27 at 4:08 PM |
| Featured Company News - Thermo Fisher's Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Gets Pre-market Approval from US FDA
finance.yahoo.com - June 26 at 5:11 PM |
| China Cord Blood Corporation (CO) Posts Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - June 22 at 10:10 AM |
| China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2017
finance.yahoo.com - June 21 at 5:38 PM |
| China Cord Blood posts 4Q profit
finance.yahoo.com - June 21 at 5:38 PM |
| China Cord Blood Corporation (CO) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - June 19 at 7:02 AM |
| [$$] Investment is in the blood for stem cell futurists
finance.yahoo.com - May 27 at 2:57 AM |
 | Investment is in the blood for stem cell futurists
www.ft.com - May 25 at 5:57 PM |
| China Cord Blood Corp (CO) Given Daily Media Impact Rating of 0.10
www.americanbankingnews.com - May 2 at 3:18 PM |
| Somewhat Positive News Coverage Extremely Likely to Impact China Cord Blood Corp (CO) Stock Price
www.americanbankingnews.com - April 28 at 4:39 PM |
| China Cord Blood Corp (CO) Getting Somewhat Positive News Coverage, Study Finds
www.americanbankingnews.com - April 25 at 4:55 PM |
| China Cord Blood Corp (CO) Earns Daily News Sentiment Score of -0.07
www.americanbankingnews.com - April 21 at 2:14 PM |
| Favorable Press Coverage Somewhat Unlikely to Affect China Cord Blood Corp (CO) Share Price
www.americanbankingnews.com - April 18 at 3:49 PM |
| China Cord Blood Corp.: Strong price momentum but will it sustain?
finance.yahoo.com - April 14 at 4:45 PM |
| China Cord Blood Corp (CO) Given News Impact Rating of 0.04
www.americanbankingnews.com - April 13 at 12:22 PM |
 | BRIEF-China Cord Blood announces termination of evaluation and negotiation regarding "going private" proposal
www.reuters.com - April 13 at 10:04 AM |
| China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding "Going Private" Proposal
finance.yahoo.com - April 13 at 10:04 AM |
| China Cord Blood Corp (CO) Expected to Announce Quarterly Sales of $0.00
www.americanbankingnews.com - April 7 at 8:31 PM |
| BRIEF-China Cord Blood Corp receives notification of exercise of 7% senior convertible notes
www.reuters.com - April 7 at 9:05 AM |
| China Cord Blood Corporation Receives Notification of Exercise of 7% Senior Convertible Notes
finance.yahoo.com - April 7 at 9:05 AM |
| BRIEF-China Cord Blood Corp names Ting Zheng interim CEO of Beijing unit
www.reuters.com - March 31 at 4:33 PM |
| China Cord Blood Corporation Announces Executive Change
finance.yahoo.com - March 31 at 4:33 PM |
China Cord Blood Corporation (CO) Chart for Tuesday, September, 19, 2017
